Correction to: Rheumatology and Therapy (2022) 9:589–608 https://doi.org/10.1007/s40744-021-00423-8

In the original publication of the article, the authors noticed some of the values in Table 1 and Table 2 of this article, the data in the column 2 and row 67 headed “Baseline patient sociodemographic and clinical characteristics” and the data in the column 3 and row 12 headed “Number of RA treatments received prior to baricitinib treatment” were incorrectly published.


The correct values should read as given below:


Table 1

Variable

Total n/mean (SD)

Hemoglobin (g/dl)

155/12.0 (4.0)


Table 2

Variable

 

N (%)

Number of previous bDMARDs (TNFi)

Total with previous TNFi

120 (66%)


The original article has been corrected.